GSK plcGSKNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR-1.3%
5Y CAGR-0.7%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-1.3%/yr
vs +15.4%/yr prior
5Y CAGR
-0.7%/yr
Consistent
Acceleration
-16.7pp
Decelerating
Percentile
P82
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
4 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 17.87% |
| Q4 2025 | 4.63% |
| Q2 2025 | 3.38% |
| Q1 2025 | -22.27% |
| Q4 2024 | -29.92% |
| Q3 2024 | 54.16% |
| Q2 2024 | 18.11% |
| Q1 2024 | -22.07% |
| Q4 2023 | 16.64% |
| Q3 2023 | 1.23% |
| Q2 2023 | 5.83% |
| Q1 2023 | -12.10% |
| Q4 2022 | 18.58% |
| Q3 2022 | -0.48% |
| Q2 2022 | 14.02% |
| Q1 2022 | -44.42% |
| Q4 2021 | 94.16% |
| Q3 2021 | -0.59% |
| Q2 2021 | -30.41% |
| Q1 2021 | -23.24% |
| Q4 2020 | 18.47% |
| Q3 2020 | -1.48% |
| Q2 2020 | -7.10% |
| Q1 2020 | -15.31% |
| Q4 2019 | 19.05% |
| Q3 2019 | 11.66% |
| Q2 2019 | 4.56% |
| Q1 2019 | -5.46% |
| Q4 2018 | 3.68% |
| Q3 2018 | 2.85% |
| Q2 2018 | 6.32% |
| Q1 2018 | -8.76% |
| Q4 2017 | 9.75% |
| Q3 2017 | -2.98% |
| Q2 2017 | -2.98% |
| Q1 2017 | -9.55% |
| Q4 2016 | 18.28% |
| Q3 2016 | 5.43% |
| Q2 2016 | -0.69% |
| Q1 2016 | -12.37% |